OBSAH

EDITORIAL ............................................................................................................................................. 1

OBSAH ................................................................................................................................................... 2

PROGRAM ............................................................................................................................................. 4

ODBORNÁ SYMPOZIA ........................................................................................................................ 10

Sympozium společnosti pro biologickou psychiatrii – emoční dysregulace napříč
psychickými poruchami ......................................................................................................................... 10

Limity a možnosti léčby antipsychotiky a neurostimulačními metodami ................................................12

Neprávem opomíjený a obávaný klozapin .............................................................................................12

Neinvazivní mozková stimulace (NIBS) napříč neuropsychiatrií – od výzkumu
ke klinické praxi ......................................................................................................................................13

Sympózium Psychofarmakologickej sekcie SPsS ..................................................................................14

Mikrobiom a možnosti jeho interakce s psychofarmaky .........................................................................16

Novinky v léčbě poruch příjmu potravy ...................................................................................................17

Ketaminem asistované psychoterapie (KAP) v léčbě celého neurotického spektra ..............................18

Nová vodítka psychiatrické společnosti ČLS JEP pro léčbu deprese ....................................................20

Intenzivní péče v psychiatrii ....................................................................................................................21

Psychedelika, problémové děti psychofarmakologie V: Stále problémové,
`nebo budoucnost? ................................................................................................................................22

Gerontopsychiatrie .................................................................................................................................23

Znepokojivé trendy v psychofarmakologii u dětí a adolescentů: Od nešťastné
psychopatologie k medicinalizaci ...........................................................................................................24

Děti, jejichž matky užívaly v těhotenství psychofarmaka: Medikovat, či nemedikovat
těhotné? ................................................................................................................................................ 25

Nové pokroky v oblasti VR terapie (terapie virtuální realitou): Ohlédnutí
za konferencí ICDVRAT 2024 ............................................................................................................... 26

Farmakodetektivky 2 ............................................................................................................................28

Neuropsychiatrické aspekty digitálních závislostí ................................................................................29

Psychedelika, problémové děti psychofarmakologie – neurobiologické okénko ..................................30

Inovace a výzvy v léčbě sexuálních dysfunkcí: od robotů po farmakologické přístupy ........................32

NOVÝ VÝZKUM ................................................................................................................................... 33

Zvýšenie endokanabinoidnej signalizácie ako cieľ pre farmakoterapiu
úzkostnýcha kognitívnych porúch ....................................................................................................... 33

Nárůst sérových hladin olanzapinu vlivem akutního zánětu ................................................................33

Vliv CB1 antagonisty / inverzního agonisty AM251 na metabolickou aktivitu P450:
`In vitro studie ..................................................................................................................................... 34

Vybrané génové varianty a odpoveď na liečbu escitalopramom u pacientov s diagnózou
depresívnej poruchy ........................................................................................................................... 34

Vztah mezi sérovou koncentrací 25(OH) vitaminu D, verbální pamětí a objemem
hipokampální šedé hmoty u pacientů s první epizodou schizofrenie ................................................. 34

Pravděpodobnostní kvantifikace trendu vlasového kortisolu pro dlouhodobé
monitorování terapie .......................................................................................................................... 35

Dynamika frontálního EEG jako indikátor odpovědi na antidepresivní léčbu:
Retrospektivní analýza pomocí Hurstova exponentu u pacientů s depresivní poruchou .................. 35

Medikační trajektorie antipsychotik a váhový přírůstek u prvotně hospitalizovaných
pacientů s první epizodou psychotického onemocnění ..................................................................... 36

VÝVĚSKOVÁ SDĚLENÍ .....................................................................................................................37

Preklinická P1–P11.................................................................................................................................37

Klinická K1–K16 .....................................................................................................................................41

WORKSHOPY ....................................................................................................................................... 49

Pohádky 1000+1 noci: interaktivně pojaté kazuistické střípky psychedelických ponorů
do nevědomého materiálu z více než tisíce ketaminových procesů na Klinice Psyon ...........................49

Algoritmus podávání off-label ketaminu v psychiatrii ................................................................................ 49

Práce s přepisem v imaginaci u transgeneračního traumatu .................................................................... 49

Deeskalace agitovaného pacienta ............................................................................................................ 50

Léčba závažných příznaků vybraných duševních poruch – EBM, umění, nebo magie?........................... 50

Farmakologická léčba ADHD u dospělých ................................................................................................ 50

REJSTŘÍK ................................................................................................................................................ 51

CONTENTS

EDITORIAL ................................................................................................................................................. 1

CONTENTS ................................................................................................................................................ 2

PROGRAM ................................................................................................................................................. 4

SCIENTIFIC SYMPOSIA ...........................................................................................................................10

Society for Biological Psychiatry Symposium– emotional dysregulation
acrosspsychiatric disorders ........................................................................................................................10

Limits and possibilities of treatment with antipsychotics and neurostimulation methods ......................... 12

Unjustly neglected and feared clozapine .................................................................................................. 12

Non-invasive brain stimulation (NIBS) across neuropsychiatry – from research
to clinical practice ......................................................................................................................................13

Symposium of the Psychopharmacological Section of the Slovak Psychiatric Society ............................ 14

The microbiome and its potential interactions with psychopharmacs ....................................................... 16

News in the treatment of eating disorders ................................................................................................. 17

Ketamine-assisted psychotherapy (KAP) in the treatment of the entire neurotic spectrum ...................... 18

New guidelines of Czech Psychiatric Society for treatment of depression ............................................... 20

Psychiatric intensive care ......................................................................................................................... 21

Psychedelics problem children of psychopharmacology V: Still problematic, or the future?..................... 22

Gerontopsychiatry .................................................................................................................................... 23

Disturbing Trends in Psychopharmacology in Children and Adolescents: From
unfortunate psychopathology to medicalization ....................................................................................... 24

Children whose mothers took psychopharmaceuticals during pregnancy: To medicate,
or not to medicate pregnant women? ....................................................................................................... 25

New advances in VR (virtual reality) therapy: A look back at the ICDVRAT 2024 conference ................. 26

Psychopharmacs detective stories 2nd .................................................................................................... 28

Neuropsychiatric aspects of digital addictions ......................................................................................... 29

Psychedelics, problem children of the psychopharmacology – neurobiological window ......................... 30

Innovations and challenges in the treatment of sexual dysfunctions: From robots
to pharmacological approaches ............................................................................................................... 32

NEW RESEARCH ................................................................................................................................... 33

Enhancement of endocannabinoid signaling as a target for pharmacotherapy
of anxiety and cognitive disorders ............................................................................................................ 33

Increase in serum olanzapine levels in acute inflammation ..................................................................... 33

Effect of the CB1 antagonist / inverse agonist AM251 on P450 metabolic activity:
An in vitro study ........................................................................................................................................ 34

Selected gene variants and escitalopram treatment response in patients
with depressive disorder ........................................................................................................................... 34

A relationship between 25(OH) vitamin D serum level, verbal memory and hippocampal
gray matter volume in first episode schizophrenia patients ...................................................................... 34

Probabilistic quantification of hair cortisol trend for long-term therapy monitoring ................................... 35

Frontal eeg dynamics as indicators of antidepressant response:
A Hurst exponent-based retrospective analysis in major depression disorder ......................................... 35

Trajectories of daily antipsychotic use and weight gain in people hospitalized
for first episode of psychosis .................................................................................................................... 36

POSTERS ................................................................................................................................................ 37

Preclinical P1–P11 ...................................................................................................................................37

Clinical K1–K16 .................................................................................................................. .................... 41

WORKSHOPS ......................................................................................................................................... 49

Tales of 1000+1 nights: interactively conceived casuistic shards of psychedelic dives
into unconscious material from over a thousand of ketamine processes at the Psyon Clinic .................. 49

Algoritm for off-label use of ketamine in psychiatry................................................................................... 49

Working with imagery rescripting in transgenerational trauma ................................................................ 49

Deescalation of agitated patient .............................................................................................................. 50

Treatment of severe symptoms of selected mental disorders – EBM, art, or magic? ............................. 50

Pharmacological treatment of ADHD in adults ........................................................................................ 50

INDEX ..................................................................................................................................................... 51

Ve výstavbě

OBSAH

EDITORIAL............................................................................................................................ 157

DIABETOLOGIE

Tomáš Pelikán, Petr Heneberg
Pokročilé trojrozměrné in vitro modely v terapii
diabetu mellitu a diabetického onemocnění ledvin:
Blíží se nová éra personalizované medicíny? ........................................................................ 162

Milan Kvapil
Filipika proti nekritickému přijímání derivovaných indexů
v diabetologii: „Klinický kontext interpretace indexu
glykace hemoglobinu HGI“ ...................................................................................................... 175

Michal Joshua Frána, Miroslav Koliba
Podiatrie v České republice a ve světě ................................................................................... 181

VÝŽIVA

Václav Pospíšil, Pavel Kohout, Petr Wohl
Kanylace centrálních žilních katétrů – praktický pohled
na národní i mezinárodní doporučení s využitím zkušeností
Centra cévních vstupů Interní kliniky 3. LF UK a FTN.............................................................. 190

ZPRÁVY

Česká diabetologická společnost ČLS JEP. Zpráva ze zasedání Výboru ............................... 197

Kongres ambulantních diabetologických týmů.......................................................................... 198

14. listopad – Světový den diabetu............................................................................................ 200

Prof. MUDr. Antonín Kazda, DrSc. ............................................................................................ 201

AKCE

Plánované mezinárodní a domácí akce..................................................................................... 204

REJSTŘÍKY 2024 ..................................................................................................................... 207

CONTENTS

EDITORIAL................................................................................................................................ 157

DIABETOLOGY

Tomáš Pelikán, Petr Heneberg
Advanced three-dimensional in vitro models in the treatment
of diabetes mellitus and diabetic kidney disease:
Is a new era of personalized medicine approaching? .............................................................. 162

Milan Kvapil
Philippic against the uncritical acceptance of derived indices
in diabetology: „The clinical context of the interpretation
of the HGI hemoglobin glycation index“ .................................................................................... 175

Michal Joshua Frána, Miroslav Koliba
Podiatry in the Czech Republic and in the world ....................................................................... 181

NUTRITION

Václav Pospíšil, Pavel Kohout, Petr Wohl
Central venous catheters insertion – a practical guide based
on the national and international guidelines and experience
of the Vascular access team of the Clinic of Internal Medicine 3rd Faculty
of Medicine Charles University and Thomayer University Hospital ............................................. 190

NEWS

Czech Diabetes Society – report from the Committee Meeting .................................................. 197

Congress of outpatient diabetology teams .................................................................................. 198

November 14th – World Diabetes Day ........................................................................................ 200

Prof. MUDr. Antonín Kazda, DrSc. .............................................................................................. 201

FUTURE EVENTS

Planned international and domestic events ................................................................................ 204

INDEX 2024 ................................................................................................................................ 207

OBSAH

EDITORIAL
Jan Vevera...................................................................................................................................129

OBSAH........................................................................................................................................132

PŘEHLEDNÉ ČLÁNKY

Vojtěch Pišl, Tereza Kohutová, Jan Vevera
Psychiatrizace: možná příčina i následek alarmujícího stavu duševního zdraví
adolescentů...................................................................................................................................134

Linda Soukupová, Daniela Dudysová, Jana Kopřivová
Akustická stimulace pomalých oscilací během spánku ............................................................... 141

Petr Dungl
Laboratorní nálezy u osob s alkoholovou epilepsií....................................................................... 148

Petra Řehořková, Lucie Švandová, Martina Sebalo Vňuková, Michaela Poslt Königová,
Radek Ptáček
Zákroky estetické medicíny a jejich psychopatologické souvislosti ...............................................152

PŘEHLEDNÉ ČLÁNKY

Zdeňka Navrátilová, Jiří Patočka
Mangostan: lahodné ovoce se slibnými účinky...............................................................................159

FÓRUM ČESKÉ NEUROPSYCHOFARMAKOLOGICKÉ SPOLEČNOSTI

Libor Ustohal, Jana Hořínková
Léčba psychózy u Parkinsonovy nemoci.........................................................................................164

ZPRÁVY

Profesoru Cyrilu Höschlovi je 75 let................................................................................................ 168

Vzpomínka na pana profesora Ptáčka............................................................................................. 169

DOPISY, OHLASY, DISKUSE

Václav Filip`
Diskusní příspěvek k editorialu Richarda Balona, Psychiatrie č. 3/2024...........................................169

REJSTŘÍKY 2024..............................................................................................................................170

POKYNY AUTORŮM..........................................................................................................................173

CONTENTS

EDITORIAL
Jan Vevera...........................................................................................................................................129

CONTENTS..........................................................................................................................................132

ORIGINAL PAPERS

Vojtěch Pišl, Tereza Kohutová, Jan Vevera
Psychiatrization: possible cause and effect of the alarming state of adolescent
mental health........................................................................................................................................134

Linda Soukupová, Daniela Dudysová, Jana Kopřivová
Acoustic stimulation of slow oscillations during sleep.......................................................................... 141

Petr Dungl
Laboratory findings of patients with alcohol-induced seizures............................................................. 148

Petra Řehořková, Lucie Švandová, Martina Sebalo Vňuková, Michaela Poslt Königová,
Radek Ptáček
Aesthetic medicine interventions and their psychopathological implications ........................................152

ORIGINAL PAPERS

Zdeňka Navrátilová, Jiří Patočka
Mangosteen: a delicious fruit with promising effects..............................................................................159

FORUM OF THE CZECH NEUROPSYCHOPHARMACOLOGICAL SOCIETY

Libor Ustohal, Jana Hořínková
Treatment of psychosis in Parkinson’s disease.......................................................................................164

NEWS

Professor Cyril Höschl 75 years old......................................................................................................... 168

Remembrance of Professor Ptáček......................................................................................................... 169

CORRESPONDENCE

Václav Filip
Discussion contribution to Richard Balon's editorial, Psychiatry No.3/2024.............................................169

INDEX 2024 ............................................................................................................................................ 170

INSTRUCTIONS FOR AUTHORS............................................................................................................173